LAYTON, UTAH, USA, February 15, 2018 /EINPresswire.com/ — Diabetes Relief is pleased to announce the opening of a new clinic in Utah. Patients suffering from diabetes and other metabolic disorders can now receive the patented treatment in Layton, Utah, just north of Salt Lake City. The Grand Opening was held on January 18, and patients are filling the appointment schedule at the Diabetes Relief treatment center at 2086 N 1700 West, Suite D, Layton UT 84041, on the campus of Davis Hospital.
“We are extremely pleased to open our first treatment center in Utah, and we are confident that our patients in the Beehive State will experience the same outstanding results and relief from the complications of diabetes that we have seen in patients around the world with this new approach to treatment,” said Stanley Lewis, MD, MPH, Chief Medical Officer of Diabetes Relief.
Patients of Diabetes Relief report being helped by Diabetes Relief’s pulsed insulin treatment more than they have found anywhere else. Brian Loveridge, MD, Regional Medical Director, said: “We are excited to help those suffering from the myriad complications of diabetes. By relieving metabolic failure, our patented infusion offers new hope in giving patients their lives back from the ravages of diabetes.”
The Diabetes Relief protocol treats insulin resistance and improves insulin sensitivity. This approach to treatment goes beyond the myopic focus on laboratory values and addresses the symptoms that confound and frustrate healthcare professionals and torment patients. Diabetes Relief clinics are also operating in Houston, San Jose, and Istanbul, with others planned for the immediate future.
Website: diabetesrelief.com
Glenn Massey, Marketing Director
Diabetes Relief LLC
281-600-5000
This press release can be viewed online at: http://www.einpresswire.com
Disclaimer: If you have any questions regarding information in this press release please contact the company listed in the press release. Please do not contact EIN Presswire. We will be unable to assist you with your inquiry. EIN Presswire disclaims any content contained in these releases. © 1995-2018 IPD Group, Inc. All Right Reserved.